Published in Pacing Clin Electrophysiol on November 01, 2000
Influence Of Inter Electrode Atrial Lead Distance On Acapconfirm™ Viability. J Atr Fibrillation (2016) 0.75
Clinical observation of atrial threshold monitoring algorithm: a single center experience. Int J Clin Exp Med (2015) 0.75
[Efficiency potential in the pacemaker/implantable cardioverter defibrillator outpatient clinic]. Herzschrittmacherther Elektrophysiol (2006) 0.75
The influence of mental and physical stress on the autocapture function in children. J Interv Card Electrophysiol (2003) 0.75
Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12
Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med (1997) 3.57
Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat Genet (2000) 2.71
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation (1994) 1.61
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) 1.57
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42
Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-up. Cathet Cardiovasc Diagn (1997) 1.40
Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol (1999) 1.15
Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12
Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol (1993) 1.10
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J (1999) 1.07
A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet (1998) 1.06
Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet (2004) 1.04
Pulmonary arterial hypertension associated to connective tissue diseases. Lupus (2005) 1.03
Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99
Evaluation of the pulse-contour method of determining stroke volume in man. Circulation (1972) 0.98
Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin Electrophysiol (2001) 0.96
AF burden is important - fact or fiction? Int J Clin Pract (2014) 0.96
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med (1997) 0.94
Italian experience with AutoCapture in conjunction with a membrane lead. Pacesetter Automatic Control of Energy and Membrane Automatic Threshold Evaluation (Pacemate) Study Group. Pacing Clin Electrophysiol (1996) 0.93
Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol (1995) 0.92
Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery. Heart (2006) 0.92
Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91
Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin. Br Heart J (1990) 0.90
Medical therapy of pulmonary hypertension. The prostacyclins. Clin Chest Med (2001) 0.88
Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients. J Heart Lung Transplant (2001) 0.85
On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes. Am J Cardiol (1993) 0.85
Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest (1998) 0.85
Autocrine and intracrine signaling for cardiogenesis in embryonic stem cells: a clue for the development of novel differentiating agents. Handb Exp Pharmacol (2006) 0.85
Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet (2005) 0.84
Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol (1998) 0.84
Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year. Pacing Clin Electrophysiol (1999) 0.83
Leukocyte subsets and cortisol serum levels in patients with migraine without aura and chronic tension-type headache. Cephalalgia (1994) 0.83
Psychological evaluation after cardiac transplantation: the integration of different criteria. Psychother Psychosom (2001) 0.83
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (2002) 0.83
Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82
Genetic heterogeneity of hypertrophic cardiomyopathy. Int J Cardiol (1985) 0.82
The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J (2002) 0.82
Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol (1999) 0.82
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract (2007) 0.81
Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects. Am J Cardiol (1993) 0.81
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. Am J Transplant (2013) 0.81
Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol (1997) 0.81
Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction. Cell Biochem Funct (1990) 0.81
Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart (2005) 0.81
Benefit of adding low molecular weight heparin to the conventional treatment of stable angina pectoris. A double-blind, randomized, placebo-controlled trial. Circulation (1993) 0.80
Comparative haemodynamic effects of transdermal vs intravenous nitroglycerin in acute myocardial infarction with elevated pulmonary artery wedge pressure. Eur Heart J (1990) 0.79
Evaluation of atrial refractoriness and atrial fibrillation inducibility immediately after internal cardioversion in patients with chronic persistent atrial fibrillation. Cardiovasc Drugs Ther (1999) 0.79
Usefulness of transesophageal echocardiographic monitoring to improve the outcome of stent-graft treatment of thoracic aortic aneurysms. Am J Cardiol (2001) 0.79
Capture window in human atrial fibrillation: evidence of an excitable gap. J Cardiovasc Electrophysiol (1999) 0.78
Effects of wave reflection timing on left ventricular mechanics. J Biomech (1999) 0.78
[Enzymatic estimation of infarct size in patients undergoing thrombolytic therapy]. Cardiologia (1988) 0.78
Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin. J Heart Lung Transplant (2000) 0.78
Pharmacological treatment of atrial fibrillation: a review on prevention of recurrences and control of ventricular response. Arch Gerontol Geriatr (2008) 0.78
Expenditure and value for money: the challenge of implantable cardioverter defibrillators. QJM (2009) 0.78
Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. Transplant Proc (2006) 0.78
Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J Cardiovasc Pharmacol (1995) 0.78
Predictors of atrial defibrillation threshold in internal cardioversion. Pacing Clin Electrophysiol (2000) 0.77
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. J Interv Cardiol (2005) 0.77
Cardiac disease after chest irradiation for Hodgkin's disease: incidence in 108 patients with long follow-up. Int J Cardiol (1995) 0.77
[Implantable defibrillators and prevention of sudden death: clinical and economic implications in the light of the MADIT II study]. Monaldi Arch Chest Dis (2002) 0.77
Involvement of multiple protein kinases in CD3-mediated activation of human T lymphocytes. Cell Immunol (1994) 0.77
Ultrastructural and immunohistochemical contribution to the histogenesis of human cardiac myxoma. Ultrastruct Pathol (1988) 0.77
Repolarization changes in a double-blind crossover study of dofetilide versus sotalol in the treatment of ventricular tachycardia. Pacing Clin Electrophysiol (2000) 0.77
Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. Chest (2000) 0.77
Cost-effectiveness of implantable cardioverter-defibrillators. Eur Heart J (2001) 0.77
Ultrasound determination of left ventricular position for volume angiography. Chest (1972) 0.77
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cells. Cancer Immunol Immunother (1990) 0.77
Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks. Int J Cardiol (1999) 0.77
[Restenosis after coronary angioplasty: its pathogenesis and prevention]. Cardiologia (1991) 0.77
Folate supplementation after heart transplantation: effects on homocysteine plasma levels and allograft vascular disease. Clin Nutr (2002) 0.77
Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile. Cardiovasc Drugs Ther (1993) 0.76
Clinical evaluation of morphology discrimination: an algorithm for rhythm discrimination in cardioverter defibrillators. Pacing Clin Electrophysiol (2001) 0.76
Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation. Am Heart J (1996) 0.76
Effects of two dosages of subcutaneous low molecular weight heparin (Parnaparin) and of unfractionated heparin on fibrin formation and lipolysis in acute myocardial infarction. Thromb Res (1992) 0.76
Biochemical correlates with myocardial aging. Cardioscience (1992) 0.76